Role of myositis-specific autoantibodies in personalized therapy
In a landmark breakthrough in 1976, Reichlin and Mattioli discovered the first myositis-specific antibody (MSA) called anti-Mi2 antibody that identified a specific clinical phenotype characterized by pathognomonic skin rash of dermatomyositis, typical proximal muscle weakness, good response to treat...
| 出版年: | Indian Journal of Rheumatology |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
SAGE Publishing
2018-01-01
|
| 主題: | |
| オンライン・アクセス: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=3;spage=186;epage=194;aulast=Malaviya |
